Agiliti, Inc. (NYSE:AGTI – Get Rating) EVP Lee M. Neumann sold 13,034 shares of the company’s stock in a transaction on Wednesday, March 15th. The stock was sold at an average price of $14.45, for a total transaction of $188,341.30. Following the completion of the transaction, the executive vice president now owns 38,647 shares of the company’s stock, valued at $558,449.15. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.
Agiliti Stock Performance
Agiliti stock opened at $14.52 on Friday. The company has a current ratio of 1.60, a quick ratio of 1.25 and a debt-to-equity ratio of 1.14. The firm has a 50-day moving average of $17.58 and a 200-day moving average of $16.90. The firm has a market cap of $1.94 billion, a P/E ratio of 69.14, a P/E/G ratio of 16.03 and a beta of 1.40. Agiliti, Inc. has a 1-year low of $14.15 and a 1-year high of $23.25.
Analyst Upgrades and Downgrades
Several research analysts recently issued reports on AGTI shares. Citigroup cut their target price on shares of Agiliti from $21.00 to $20.00 and set a “buy” rating for the company in a research report on Wednesday, March 8th. Bank of America lowered shares of Agiliti from a “buy” rating to a “neutral” rating and set a $19.00 price target for the company. in a research report on Friday, December 16th. Finally, Morgan Stanley lowered shares of Agiliti from an “overweight” rating to an “equal weight” rating and set a $18.00 price target for the company. in a research report on Friday, January 6th. Two research analysts have rated the stock with a hold rating and five have given a buy rating to the company. According to data from MarketBeat, Agiliti presently has an average rating of “Moderate Buy” and an average target price of $20.88.
Hedge Funds Weigh In On Agiliti
About Agiliti
Agiliti, Inc provides end-to-end healthcare technology management and service solutions to the United States healthcare industry. It also offers comprehensive medical equipment management and service solutions to reduce capital and operating expenses, increase medical equipment and staff productivity and support improved patient safety and outcomes.
Recommended Stories
- Get a free copy of the StockNews.com research report on Agiliti (AGTI)
- MarketBeat Week in Review – 3/13 – 3/17
- This Small Tech With Big Growth Prospects Is Nearing A Buy Point
- Don’t Chase FedEx Higher, Wait For The Pullback
- 3 Stocks For A Defensive Tech Portfolio
- Milk the Dividends on These 3 Cash Cows
Receive News & Ratings for Agiliti Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agiliti and related companies with MarketBeat.com's FREE daily email newsletter.